All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Deals, Development and Manufacturing
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
Global Perspectives
Intellectual Property & Patents
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
Mergers and Acquisitions
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Deals, Development and Manufacturing
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
Global Perspectives
Intellectual Property & Patents
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
Mergers and Acquisitions
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Why use LIMS and related software

May 1, 2006
By Christian Stage
Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-05-01-2006
Volume 18
Issue 5

A laboratory information management system (LIMS) can control, manage, organize and document information thus saving time and money.

What is LIMS and how can it help you?

A laboratory information management system (LIMS) can control, manage, organize and document information thus saving time and money. Locating certain types of production information or documentation can be easily fulfilled using software search functions. The ability to automate more procedures reduces the risk for human error and allows personnel to be used for other types of work providing a better cost benefit ratio. All these parameters should work together to reduce the time and cost of production.

Which environments can it be used in?

LIMS software systems started with small, closed, in-house solutions in the 1970s. In the 1980s, commercial products became available when software was installed on computers linked together in a closed network system. The software was usually specific to a certain instrument supplier and used a proprietary data format to protect the product and keep customers reliant on the brand. Technical improvements led to faster and more open client server systems becoming available in the 1990s. Modern systems are open client server web-based systems using Microsoft .Net technology.

Which type of LIMS to choose?

In general there are three options available to a company. It can decide to program an in-house, proprietary system fulfiling all local company demands. Alternatively it may buy a commercial product and modify it to fulfil local demands, a process known as customization. The last solution is to buy a standard program covering most of the needs of the project, known as a commercial off-the-shelf (COTS) solution. Parameters such as initial price, licence price, implementation time, updatability, staff training, design and ease of use, CFR 21 Part 11 compliance, audit trails, electronic signatures and validation should be taken in consideration before selecting a new LIMS software system.

What about software security and validation?

A lot of laboratories and production units are controlled be regulatory rules. Working with software with traceability options offers huge benefits when solving technical problems and complying with documentation demands. All pharmaceutical companies must adhere to the 21 CFR Part 11 regulation including electronic signatures and audit trails. Traceability is the key component of solving many technical challenges. The technical development of the computers, advanced modern software technology, standardized result formats, LIMS flexibility and performance has reached a level where it can offer most users large scale options to make life easier.

Which applications can it support?

LIMS software is traditionally found in analytical laboratories such as R&D labs, in-process testing labs and quality assurance (QA) labs. Technical developments and increasing demands in other industrial areas has seen LIMS placed in environmental labs, industrial labs, and pharmaceutical and life science labs. LIMS is designed to be linked to analytical equipment through an interface box. Depending on the size and type of the LIMS, the following procedures can be undertaken:

  • A working table may be set up.

  • Samples identified.

  • Analytical parameters defined.

  • Samples analysed.

  • Results approved and electronically signed.

Manufacturing industries where individual components are used may need to track objects incorporated into many products reliably across the globe. Achieving this task without the aid of a LIMS type system would be extremely difficult.

Reducing the time-to-market is a priority in the pharma industry, with development costs rising rapidly. LIMS software can be used to optimize the instrumental analytical capacity for testing different samples using resources in the most efficient way. During the regular inspections, which form part of the industry's tight regulation, a searchable electronic database created by a LIMS system is invaluable.

How is data reliably and securely matched and extracted from the database?

With increasingly complex networks and multiple feeds to a central server, software is needed to collate and sort information. The central software is typically a relational database, for example an SQL database. If the information has varying formats a translation module must be programmed to standardize the data for ease of analysis.

The central software must have maximum security to comply with 21 CFR Part 11 including user name, password (including rotation rules), electronic signature and audit trail. It must not be possible to delete data using the Microsoft "explore" functionality, though data may be inactivated. If necessary it must be possible to "reactivate" the data to comply with regulatory requests. All risk-based actions must be documented in the audit trail and validated. Any critical parameter able to influence the final judgment of the data must be checked (validated). When combining and modifying data formats it is difficult to keep the audit trail and track all calibration data/off set values. If one of the programs is updated, it may be necessary to change or modify all linked programs with a following complete validation of all parameters.

With all data in the same database, statistics, calculations and baselines might be extracted. To create statistic reports the correct data must be present. The correct data is normally produced using the software search functionality. All statistic and search functions must be validated to ensure that all data are present and calculations are performed according to an accepted standard. Using different calculators may cause small differences in the calculated results. The differences are due to how many decimals are used and the rounding technique. Routine calculations may be programmed as macros. Some programs may create a baseline report meaning that the user can get a summary report at a certain time stamp showing the status of all parameters.4 Even if there are no external authorities demanding a validation or similar documentation it is strongly advisable to test any software doing the target task in the local environment.

Conclusion

Using a LIMS software system may increase efficiency if the needs of user are matched, the system is implemented in a proper way, validated according to local demands, properly configured to local structure and if incoming data arrives in the same format. The system must be continuously updated and a back-up procedure defined. Modern technology and software development has improved LIMS flexibility and performance to a level where it can offer most users large scale options to make life easier. Generally speaking, the LIMS system started as a "narrow" software solution supporting only few applications but today it is much more standardized and able to support a huge range of applications.

Christian Stage is director of QA product development at QAtor, Denmark.

Bibliography

1. R. Wagner, Pharm. Technol. Eur. 17(12), 54–57 (2005).

2. Title 21 Code of Federal Regulations Part 11 (21 CFR Part 11) U. S. Food and Drug Administration, 5600 Fishers Lane, Rockville MD 20857-0001 www.fda.gov/ora/compliance_ref/part11.

3. H. Gillespie, Scientific Computing & Automation, June (1994)

4. C. Stage, Pharm.Technol. Eur. 17(8),13–15 (2005).

5. Today's Chemist at Work, 1998, 7(2), 79–80, 82, 84. Copyright 1998 by the American Chemical Society.

6. C. Stage, Pharm. Technol. Eur. 18 (2) 16-18

Articles in this issue

A guide for testing biopharmaceuticals — Part I: general strategies for validation extensions
A guide for testing biopharmaceuticals — Part I: general strategies for validation extensions
Parallel trade and free movement
The process analytical technology market
The process analytical technology market
Creating a compelling business case for your LIMS implementation
Creating a compelling business case for your LIMS implementation
Integrating PAT with MES
Integrating PAT with MES
Using remote monitoring to boost performance
Using remote monitoring to boost performance
Why use LIMS and related software
Why use LIMS and related software
Trust in medicines
Trust in medicines
Marking and coding: the key to combating counterfeiting
Marking and coding: the key to combating counterfeiting
Recent Videos
INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement
INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Industry Outlook 2025: Continuing Innovation
Process Development Benefits from Automated Analytical Technologies
Process Development Benefits from Automated Analytical Technologies
The Impact of USP Chapter <86> on Endotoxin Testing
The Impact of USP Chapter <86> on Endotoxin Testing
BIO 2024: CDMOs Focus on Complex Technical Challenges to Boost Startup Biotechs
BIO 2024: CDMOs Focus on Complex Technical Challenges to Boost Startup Biotechs
AAPS PharmSci 360: The Importance of HCP Analysis in Biomanufacturing
AAPS PharmSci 360: The Importance of HCP Analysis in Biomanufacturing
AAPS PharmSci 306: Trends in New Analytical Tools for RNA Characterization
AAPS PharmSci 306: Trends in New Analytical Tools for RNA Characterization
AAPS PharmSci 360: Advancements and Challenges in Large RNA Therapeutics
AAPS PharmSci 360: Advancements and Challenges in Large RNA Therapeutics
Applying AI to Molecular Structure (BIO 2024)
Applying AI to Molecular Structure (BIO 2024)
A Look at Translational CROs and PDC Modeling (BIO 2024)
A Look at Translational CROs and PDC Modeling (BIO 2024)
Related Content
Advertisement

Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.


TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

Patrick Lavery
April 8th 2025
Article

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.


Macro view on vials | Image Credit: © yuriygolub - stock.adobe.com

Extractable and Leachable Challenges in Lyophilized Drug Products

Alan Xu;Piet Christiaens
April 5th 2025
Article

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.


Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
March 28th 2025
Article

The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.


concept of industry 4 0 technology automation system with cloud computing | Image Credit: © Sasirat - © Sasirat - stock.adobe.com

Accelerating Adoption of Smart Tools to Advance Manufacturing

Feliza Mirasol
March 12th 2025
Article

Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.

Related Content
Analytics
|
Data and Artificial Intelligence
Advertisement

Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.


TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

Patrick Lavery
April 8th 2025
Article

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.


Macro view on vials | Image Credit: © yuriygolub - stock.adobe.com

Extractable and Leachable Challenges in Lyophilized Drug Products

Alan Xu;Piet Christiaens
April 5th 2025
Article

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.


Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
March 28th 2025
Article

The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.


concept of industry 4 0 technology automation system with cloud computing | Image Credit: © Sasirat - © Sasirat - stock.adobe.com

Accelerating Adoption of Smart Tools to Advance Manufacturing

Feliza Mirasol
March 12th 2025
Article

Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.

Advertisement
Advertisement
Advertisement
x
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.